Related Experiment Video
Updated: Jun 18, 2025

06:27
Wireless Telemetry Device Implantation in a Fontan Ovine Model for Continuous and Long-Term Hemodynamic Monitoring
Published on: May 2, 2025
104
Patient Reported Outcome Measures in Adults with Fontan Circulatory Failure
Guillermo Agorrody1, Isaac Begun1, Subodh Verma2
1Toronto Adult Congenital Heart Disease Program, Peter Munk Cardiac Centre, Division of Cardiology, University Health Network, University of Toronto, Toronto, ON M5G 2N2, Canada.
Journal of Clinical Medicine
|July 27, 2024
Summary
Patient-reported outcome (PRO) surveys, particularly the Kansas City Cardiomyopathy Questionnaire (KCCQ-12), effectively identify Fontan circulatory failure (FCF) in adults with congenital heart disease. Combining KCCQ-12 with other PROs further enhances FCF detection.
Area of Science:
- Cardiology
- Adult Congenital Heart Disease (ACHD)
- Patient-Reported Outcomes (PROs)
Background:
- Patient-reported outcomes (PROs) are crucial for assessing acquired heart disease but lack definition in Adult Congenital Heart Disease (ACHD).
- Fontan circulatory failure (FCF) is a significant concern in ACHD, necessitating validated assessment tools.
Purpose of the Study:
- To evaluate the discriminatory capacity of various PRO survey tools in identifying Fontan circulatory failure (FCF).
- To determine if combining PRO tools improves the detection of FCF in ACHD patients.
Main Methods:
- Consecutive adult patients with Fontan circulation or simple shunt lesions completed a comprehensive package of PRO measures.
- PRO tools included the Kansas City Cardiomyopathy Questionnaire (KCCQ-12), EuroQol-5-dimension (EQ5D), Short Form Health Status Survey (SF-12), self-reported NYHA Functional Class, and Specific Activity Scale (SAS).
- Statistical analysis compared PRO scores between Fontan and shunt lesion patients, and between FCF and non-FCF subgroups.
Main Results:
- Fontan patients reported lower KCCQ-12 scores compared to simple shunt lesion patients (p < 0.001).
- Patients with FCF exhibited significantly lower KCCQ-12 scores than those without FCF (p = 0.002).
- The KCCQ-12 demonstrated good discriminatory capacity for FCF (c-statistic 0.75), which improved to 0.82 when combined with other PRO tools.
Conclusions:
- The KCCQ-12 questionnaire is a valuable tool for identifying FCF in ACHD.
- Combining KCCQ-12 with complementary PRO tools enhances the detection of FCF.
- Further research is needed to establish the role of PROs in guiding ACHD management strategies.

